Maurice Hilleman
#2,430
Most Influential Person Now
American vaccinologist
Maurice Hilleman's AcademicInfluence.com Rankings
Maurice Hillemanbiology Degrees
Biology
#339
World Rank
#609
Historical Rank
#199
USA Rank
Virology
#30
World Rank
#32
Historical Rank
#12
USA Rank
Microbiology
#27
World Rank
#40
Historical Rank
#18
USA Rank
Immunology
#104
World Rank
#110
Historical Rank
#36
USA Rank
Download Badge
Biology
Maurice Hilleman's Degrees
- PhD Microbiology University of Chicago
Why Is Maurice Hilleman Influential?
(Suggest an Edit or Addition)According to Wikipedia, Maurice Ralph Hilleman was a leading American microbiologist who specialized in vaccinology and developed over 40 vaccines, an unparalleled record of productivity. According to one estimate, his vaccines save nearly eight million lives each year. He has been described as one of the most influential vaccinologists ever.
Maurice Hilleman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Human hepatitis B vaccine from recombinant yeast (1984) (694)
- Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. (1967) (673)
- The Vacuolating Virus, S.V.40 (1960) (463)
- Live attenuated varicella virus vaccine. Efficacy trial in healthy children. (1984) (415)
- Propagation of Human Hepatitis A Virus in Cell Culture in Vitro (1979) (383)
- Protective efficacy of pneumococcal polysaccharide vaccines. (1977) (339)
- Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. (2002) (332)
- Inducers of interferon and host resistance. I. Double-stranded RNA from extracts of Penicillium funiculosum. (1967) (259)
- Vaccination and Revaccination with Polyvalent Pneumococcal Polysaccharide Vaccines in Adults and Infants (1978) (240)
- Development of Tumors in Hamsters Inoculated in the Neonatal Period with Vacuolating Virus, SV40 ∗ (1962) (212)
- Vaccines in historic evolution and perspective: a narrative of vaccine discoveries. (2000) (201)
- Adenoviruses: group name proposed for new respiratory-tract viruses. (1956) (193)
- Live, attenuated mumps-virus vaccine. (1968) (188)
- Purification and Characterization of Chick Embryo Interferon (1963) (174)
- Specific Immune Adherence Assay for Human Hepatitis A Antibody. Application to Diagnostic and Epidemiologic Investigations (1975) (174)
- Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections (2004) (170)
- Antigenic variation of influenza viruses. (1954) (158)
- Live Attenuated Mumps Virus Vaccine. 1. Vaccine Development (1966) (155)
- Contributions to Characterization and Classification of Animal Viruses (1963) (138)
- Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines. (1981) (131)
- Inducers of interferon and host resistance. 3. Double-stranded RNA from reovirus type 3 virions (reo 3-RNA). (1967) (130)
- Characterization and Classification of ECHO 28-Rhinovirus-Coryzavirus Agents (1962) (124)
- Development and evaluation of the Moraten measles virus vaccine. (1968) (122)
- Purified and inactivated human hepatitis B vaccine: progress report. (1975) (119)
- Physical, Chemical and Morphologic Dimensions of Human Hepatitis A Virus Strain CR326 (1975) (116)
- Inducers of interferon and host resistance, V. In vitro studies. (1968) (116)
- Inducers of interferon and host resistance, IV. Double-stranded replicative form RNA (MS2-Ff-RNA) from E. coli infected with MS2 coliphage. (1967) (114)
- Evidence for viral hepatitis other than type A or type B among persons in Costa Rica. (1975) (110)
- Pneumococcal Vaccines (1978) (107)
- Vaccine against human hepatitis B. (1976) (105)
- Live attenuated mumps-virus vaccine. IV. Protective efficacy as measured in a field evaluation. (1967) (102)
- Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications. (2001) (102)
- Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus. (2003) (94)
- New Findings in Live, Attenuated Hepatitis A Vaccine Development (1986) (92)
- Acute respiratory illnesses among children and adults. Field study of contemporary importance of several viruses and appraisal of the literature. (1962) (91)
- Etiologic Relationship of Marmoset-Propagated CR326 Hepatitis A Virus to Hepatitis in Man (1973) (89)
- Overview of the pathogenesis, prophylaxis and therapeusis of viral hepatitis B, with focus on reduction to practical applications. (2001) (89)
- Live attenuated mumps-virus vaccine. 3. Clinical and serologic aspects in a field evaluation. (1967) (86)
- Tests in Hamsters for Oncogenic Quality of Ordinary Viruses Including Adenovirus Type 7.∗ (1964) (81)
- Overview: cause and prevention in biowarfare and bioterrorism. (2002) (79)
- Studies in Human Subjects of Polyvalent Pneumococcal Vaccines (1977) (78)
- Interruption of SV40 Virus Tumorigenesis Using Irradiated Homologous Tumor Antigen.∗ (1964) (76)
- Combined live measles, mumps, and rubella virus vaccines. (1969) (76)
- Inducers of Interferon and Host Resistance VI. Antiviral Efficacy of Poly I:C in Animal Models (1969) (73)
- Recovery of Hepatitis Agents in the Marmoset from Human Cases Occurring in Costa Rica (1973) (66)
- Progress toward a Live, Attenuated Human Hepatitis A Vaccine (1982) (66)
- Prospects for the use of double-stranded ribonucleic acid (poly I:C) inducers in man. (1970) (66)
- Recovery of New Viruses (Coryzavirus) from Cases of Common Cold in Human Adults (1961) (64)
- EPIDEMIOLOGY OF ADENOVIRUS RESPIRATORY INFECTIONS IN MILITARY RECRUIT POPULATIONS (1957) (62)
- Clinical and Laboratory Studies of Live Cytomegalovirus Vaccine Ad-169 (1979) (62)
- Clinical and Laboratory Studies of Combined Live Measles, Mumps, and Rubella Vaccines Using the RA 27/3 Rubella Virus (1980) (60)
- Studies of acute respiratory illnesses caused by respiratory syncytial virus. 3. Clinical and laboratory findings. (1961) (58)
- Persistence of Antibody in Human Subjects for 7 to 10 Years following Administration of Combined Live Attenuated Measles, Mumps, and Rubella Virus Vaccines (1980) (56)
- Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies. (1971) (55)
- New Antigenic Variant in Far East Influenza Epidemic, 1957 (1957) (54)
- Live attenuated rubella virus vaccines prepared in duck embryo cell culture. I. Development and clinical testing. (1968) (53)
- Six decades of vaccine development—a personal history (1998) (50)
- Factors Influencing Tumor Induction in Hamsters by Vacuolating Virus, SV40.∗ (1963) (49)
- Critical appraisal of emulsified oil adjuvants applied to viral vaccines. (1966) (49)
- Yeast recombinant hepatitis B vaccine (2005) (48)
- Stability on storage at various temperatures of live measles, mumps and rubella virus vaccines in new stabilizer. (1980) (47)
- Living attenuated measles-virus vaccine in early infancy. Studies of the role of passive antibody in immunization. (1961) (47)
- Double-stranded RNAs (poly I:C) in the prevention of viral infections. (1970) (47)
- Induction of Interferon in Human Subjects by Poly I:C (1971) (47)
- Clinical and Laboratory Studies of KMcC Strain Live Attenuated Varicella Virus (1981) (46)
- Use of living attenuated measles-virus vaccine in early infancy. (1960) (46)
- Immunological Studies on the Psittacosis-lymphogranuloma Group of Viral Agents (1945) (46)
- DNA vaccines : a new era in vaccinology (1995) (45)
- Immunologic studies of measles. (1961) (45)
- Epidemiologic investigations with respiratory disease virus RI-67. (1955) (45)
- Seroepidemiologic Investigations of Human Hepatitis Caused by A, B, and a Possible Third Virus 1 (1976) (44)
- Long-term follow-up for immunity after monovalent or combined live measles, mumps, and rubella virus vaccines. (1975) (44)
- Studies of acute respiratory illnesses caused by respiratory syncytial virus. 2. Epidemiology and assessment of importance. (1961) (43)
- Summary of worldwide clinical experience with H-B-Vax (B, MSD). (1983) (43)
- Interferon induction and utilization (1968) (43)
- Vaccinology, immunology, and comparative pathogenesis of measles in the quest for a preventative against AIDS. (1994) (43)
- Live, attenuated rubella-virus vaccine. (1968) (42)
- Hyperpotentiation by Synthetic Double-Stranded RNA of Antibody Responses to Influenza Virus Vaccine in Adjuvant 65 (1969) (41)
- Efficacy of Live, Attenuated Measles-Virus Vaccine given with Human Immune Globulin. A Preliminary Report. (1961) (40)
- Live attenuated rubella virus vaccines. Experiences with duck embryo cell preparations. (1969) (39)
- Newer directions in vaccine development and utilization. (1985) (39)
- Live rubella vaccines in adults and children. HPV-77 and Merck-Benoit strains. (1969) (39)
- Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines. (1978) (39)
- The indirect complement fixation hemagglutination and conglutinating complement absorption tests for viruses of the psittacosis-lymphogranuloma venereum group. (1951) (38)
- Polyvalent pneumococcal polysaccharide vaccines. (1979) (38)
- Live attenuated rubella virus vaccines prepared in duck embryo cell culture. II. Clinical tests in families and in an institution. (1968) (38)
- The Induction of Interferon (1971) (38)
- Rubella Vaccination in Adult Females (1969) (38)
- Personal historical chronicle of six decades of basic and applied research in virology, immunology, and vaccinology (1999) (37)
- Haemophilus influenzae Type b Polysaccharide-Protein Conjugate Vaccine (1987) (37)
- Enzyme-linked immunosorbent assay for measurement of antibodies against pneumococcal polysaccharide antigens: comparison with radioimmunoassay (1979) (37)
- IMMUNOLOGIC, CHEMOTHERAPEUTIC AND INTERFERON APPROACHES TO CONTROL OF VIRAL DISEASE. (1965) (36)
- Comparison of Neutralization and Hemagglutination-Inhibition Techniques for Measuring Mumps Antibody (1967) (36)
- Prevention of Acute Respiratory Illness in Recruits by Adenovirus∗ (RI-APC-ARD) Vaccine.† (1956) (36)
- Biophysical Characterization of the RI (RI-67) Viruses.∗ (1955) (36)
- Grouping and Occurrence of RI (Prototype RI-67) Viruses.∗ (1955) (35)
- New Metabolizable Immunologic Adjuvant∗ for Human Use. I. Development and Animal Immune Response (1964) (35)
- Herpes simplex vaccines. (1976) (35)
- Clinical and laboratory studies in patients with respiratory disease caused by adenoviruses (RI-APC-ARD agents). (1956) (35)
- Clinical and laboratory findings in cases of respiratory illness caused by coryzaviruses. (1962) (34)
- The preparation and safety of hepatitis B vaccine. (1983) (34)
- Appraisal of occurrence of adenovirus-caused respiratory illness in military populations. (1957) (33)
- Discovery of simian virus 40 (SV40) and its relationship to poliomyelitis virus vaccines. (1998) (33)
- A simplified vaccinologists' vaccinology and the pursuit of a vaccine against AIDS. (1998) (33)
- Studies of Acute Respiratory Illnesses Caused by Respiratory Syncytial Virus. 1. Laboratory Findings in 109 Cases (1961) (32)
- Antibody response in volunteers to Asian influenza vaccine. (1958) (32)
- Characterization of Chick Embryo Interferon Induced by a DNA Virus (1965) (32)
- Therapeutic vaccines: Realities of today and hopes for tomorrow (2004) (31)
- Epidemiology of RI(RI-67) group respiratory virus infections in recruit populations. (1955) (31)
- INTERFERON IN PROSPECT AND PERSPECTIVE. (1963) (30)
- Live Respiratory Syncytial Virus Vaccine Administered Parenterally (1978) (30)
- Live attenuated mumps virus vaccine. II. Early clinical studies. (1967) (30)
- Follow-Up Surveillance for Antibody in Human Subjects following Live Attenuated Measles, Mumps, and Rubella Virus Vaccines (1979) (30)
- Influence of age on clinical response to HPV-77 duck rubella vaccine. (1972) (30)
- Overview of the Needs and Realities for Developing New and Improved Vaccines in the 21st Century (2003) (29)
- Clinical and Laboratory Studies of Live Attenuated RA 27/3 and HPV 77-DE Rubella Virus Vaccines (1980) (29)
- Differentiation of Virulent from Avirulent Measles Strains (1962) (29)
- Pathogenicity and oncolytic capacity of RI virus strain RI-67 in man. (1956) (29)
- The clinical application of adjuvant 65. (1972) (29)
- Comparative biology and pathogenesis of AIDS and hepatitis B viruses: related but different. (1994) (28)
- Epidemiologic Investigations of Rhinovirus Infections (1964) (28)
- Influence of Synthetic Double-Stranded Ribonucleic Acid, Poly I:G, on Friend Leukemia in Mice 1 (1969) (28)
- Overview of vaccinology with special reference to papillomavirus vaccines. (2000) (28)
- Vaccines in historic evolution and perspective: a narrative of vaccine discoveries. (2000) (28)
- Further Investigations of Live Respiratory Syncytial Virus Vaccine Administered Parenterally (1979) (28)
- Past, present, and future of measles, mumps, and rubella virus vaccines. (1992) (27)
- Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. I. Properties of the SF-4 (shipping fever) strain of virus. (1961) (27)
- Hepatitis and hepatitis A vaccine: a glimpse of history. (1993) (27)
- Chemotherapy in bubonic lymphogranuloma venereum: a clinical and serological evaluation. (1957) (27)
- Impediments, imponderables and alternatives in the attempt to develop an effective vaccine against AIDS. (1992) (27)
- Influence of Synthetic (Poly I:C) and Viral Double-Stranded Ribonucleic Acids on Adenovirus 12 Oncogenesis in Hamsters∗ (1969) (27)
- Advances in control of viral infections by nonspecific measures and by vaccines, with special reference to live mumps and rubella virus vaccines (1966) (27)
- Additional Rhinovirus Serotypes (1964) (26)
- POLY I:C, AN INDUCER OF INTERFERON AND INTERFERENCE AGAINST VIRUS INFECTIONS (1972) (26)
- Feline leukemia virus envelope glycoprotein vaccine: preparation and evaluation of immunizing potency in guinea pig and cat. (1978) (26)
- Critical appraisal of emulsified oil adjuvants applied to viral vaccines. (1966) (26)
- Clinical manifestations, according to age, among females given HPV-77 duck rubella vaccine. (1971) (25)
- Distribution and significance of Asian and other influenza antibodies in the human population. (1958) (25)
- Influenza antibodies in the population of the USA; an epidemiological investigation. (1953) (25)
- Studies of Oncogenicity of Adenovirus Type 7 Viruses in Hamsters.∗ (1965) (25)
- Rubella virus vaccine (HPV-77-DE 5). Antigenic and protective efficacy in a community trial. (1969) (25)
- Influence of Synthetic Double-Stranded Ribonucleic Acid (Poly I: C) on SV40 Viral Oncogenesis and Transplant Tumor in Hamsters 1 (1970) (24)
- Enders' live measles-virus vaccine with human immune globulin. I. Clinical reactions. (1962) (24)
- OUTBREAK OF ACUTE RESPIRATORY ILLNESS CAUSED BY RI-67 AND INFLUENZA A VIRUSES, FORT LEONARD WOOD, 1952–1953, (1955) (24)
- Development and utilization of complement-fixation and immune adherence tests for human hepatitis A virus and antibody. (1975) (24)
- Human hepatitis B vaccine from recombinant yeast. 1984. (1992) (23)
- Poly I:C/poly-L-lysine: potent inducer of interferons in primates. (1981) (23)
- Toward control of viral infections of man. (1969) (23)
- Studies for safety of adjuvant 65. (1972) (23)
- Respiratory virus vaccines. V. Field evaluation for efficacy of heptavalent vaccine. (1966) (23)
- History, precedent, and progress in the development of mammalian cell culture systems for preparing vaccines: Safety considerations revisited (1990) (22)
- Studies of live attenuated measles virus vaccine in man. II. Appraisal of efficacy. (1962) (22)
- Effective Treatment of Experimental Herpes Simplex Keratitis with New Derivative, 5-Methylamino-2′-Deoxyuridine (MADU) (1965) (21)
- Antigenic Pattern of Strains of Influenza A and B (1950) (21)
- Jeryl Lynn Strain Live Attenuated Mumps Virus Vaccine: Influence of Age, Virus Dose, Lot, and γGlobulin Administration on Response (1968) (21)
- Ender's live measles-virus vaccine with human immune globulin. II. Evaluation of efficacy. (1962) (21)
- Production of purified hepatitis B surface antigen from Alexander hepatoma cells grown in artificial capillary units. (1983) (21)
- Antibody response in volunteers to adenovirus vaccine and correlation of antibody with immunity. (1958) (20)
- Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. III. Evaluation of an SF-4 (shipping fever) virus vaccine in cattle. (1961) (20)
- Electron microscopy of type 4 adenovirus strain R1-67. (1957) (20)
- Line cell saga - an argument in favor of production of biologics in cancer cells. (1979) (19)
- Vaccine Supply and Innovation (1987) (19)
- Studies of live attenuated measles virus vaccine in man. I. Clinical aspects. (1962) (19)
- Marek's disease vaccine: its implications in biology and medicine. (1972) (19)
- Influence of non-specific inhibitor on the diagnostic hemagglutination-inhibition test for influenza. (1953) (19)
- Double-Stranded Polynucleotides as Interferon Inducers (1970) (19)
- Administration of Enders' live measles virus vaccine with human immune globulin. (1962) (18)
- ADENOVIRUS (RI-APC-ARD) VACCINE FOR PREVENTION OF ACUTE RESPIRATORY ILLNESS: 2. FIELD EVALUATION (1957) (18)
- Studies on lymphogranuloma venereum complement-fixing antigens; enhancement by phenol or boiling. (1946) (18)
- Prevention of SV40 Virus Tumorigenesis by Irradiated, Disrupted and Iododeoxyuridine Treated Tumor Cell Antigens.∗ (1967) (18)
- Rubella vaccination in adult females. (1969) (17)
- RESPIRATORY SYNCYTIAL VIRUS. (1963) (17)
- Vaccines made from recombinant yeast cells. (1986) (17)
- Experiences with Jeryl Lynn strain live attenuated mumps virus vaccine in a pediatric outpatient clinic. (1967) (17)
- Further Tests in Hamsters for Oncogenic Quality of Ordinary Viruses and Mycoplasma, with Correlative Review.∗ (1965) (17)
- Clinical-laboratory experiences with combined dried live measles-smallpox vaccine. (1966) (17)
- Laboratory studies on the 1950 outbreak of influenza. (1950) (17)
- Multiple Molecular Species of Interferons of Mouse and of Rabbit Origin (1966) (17)
- Combined live measles-mumps virus vaccine. (1973) (16)
- Overview: practical insights from comparative immunology and pathogenesis of AIDS, hepatitis B, and measles for developing an HIV vaccine. (1995) (16)
- Efficacy of and indications for use of adenovirus vaccine. (1958) (16)
- Protective efficacy of duck embryo rubella vaccines. (1969) (16)
- New Metabolizable Immunologic Adjuvant∗ for Human Use. 2. Short-term Animal Toxicity Tests (1964) (16)
- Combined live rubella-mumps virus vaccine. Findings in clinical-laboratory studies. (1971) (16)
- Second field evaluation of bivalent Types 4 and 7 adenovirus vaccine. (1958) (16)
- Vaccination of adults with live attenuated mumps virus vaccine. (1967) (15)
- Physical, chemical and morphologic dimensions of human hepatitis A virus strain CR326 (38578). (1975) (15)
- Scale‐up of Chick Cell Growth on Microcarriers in Fermenters for Vaccine Production (1983) (15)
- Respiratory Tract Diseases. (1961) (15)
- DNA Vectors Precedents and Safety (1995) (15)
- Combined live measles-rubella virus vaccine. Findings in clinical laboratory studies. (1971) (15)
- Biophysical and biochemical properties of CR326 human hepatitis A virus. (1975) (15)
- THE PARAINFLUENZA VIRUSES OF MAN (1962) (15)
- Recombinant vector vaccines in vaccinology. (1994) (15)
- Enhancement in hamsters of virus oncogenesis attending vaccination procedures. (1965) (15)
- System for Measuring and Designating Antigenic Components of Influenza Viruses with Analyses of Recently Isolated Strains (1951) (15)
- Search for Virus in Human Malignancies. 1. In vitro Studies.∗ (1962) (15)
- Respiratory virus vaccines. VII. Field evaluation of respiratory syncytial, parainfluenza 1, 2, 3, and Mycoplasma pneumoniae vaccines, 1965 to 1966. (1967) (14)
- Adenovirus (RI-APC-ARD) vaccine for prevention of acute respiratory illness. I. Vaccine development. (1957) (14)
- Whether and when an AIDS vaccine? (1995) (14)
- Respiratory viruses and respiratory virus vaccines. (1963) (14)
- Respiratory virus vaccines. 8. Field evaluation of trivalent parainfluenza virus vaccine among preschool children in families, 1967-1968. (1969) (14)
- The dilemma of AIDS vaccine and therapy. Possible clues from comparative pathogenesis with measles. (1992) (14)
- Quality and safety of human hepatitis B vaccine. (1983) (14)
- Failure of Thymopoietin, Ubiquitin and Synthetic Serum Thymic Factor to Restore Immunocompetence in T-Cell Deficient Mice (1978) (14)
- Antigenic relationships among adenoviruses with appraisal of reliability of complement-fixation test for typing isolates. (1958) (13)
- Measurement of immunity following live mumps (5 years), measles (3 years), and rubella (2 and one-half years) virus vaccines. (1972) (13)
- Studies on lymphogranuloma venereum complement-fixing antigens the solubility in ether of an active fraction. (1946) (13)
- Jeryl Lynn strain live mumps virus vaccine. Durable immunity for three years following vaccination. (1969) (13)
- Host-Virus Relationships in Hamsters Inoculated with SV40 Virus During the Neonatal Period.∗ (1964) (13)
- Attempt at Immunization by Oral Feeding of Live Rhinoviruses in Enteric-Coated Capsules (1966) (13)
- Development of a purified poliomyelitis virus vaccine. (1961) (12)
- Cooperation between government and industry in combating a perceived emerging pandemic. The 1976 swine influenza vaccination program. (1996) (12)
- Vaccination against acute respiratory illness of adenovirus (RI-APC-ARD) etiology. (1957) (12)
- Ten-Year Follow-Up Study for Safety of Adjuvant 65 Influenza Vaccine in Man (1973) (12)
- Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines. (1973) (12)
- Immunologic Relations of the Psittacosis-Lymphogranuloma Group of Viral Agents.∗ (1944) (12)
- Viruses of special interest to the dermatologist; a review. (1950) (12)
- Studies on Induction of Virus from Adenovirus and SV40 Hamster Tumors 1. Chemical and Physical Agents.∗ (1966) (12)
- The business of science and the science of business in the quest for an AIDS vaccine. (1999) (12)
- Persistent immunity following Enders live, attenuated measles-virus vaccine given with human immune globulin. (1962) (11)
- New metabolizable immunologic adjuvant for human use. X. Long-term serologic and clinical follow-up. (1970) (11)
- Jeryl Lynn strain live attenuated mumps virus vaccine. Durability of immunity following administration. (1968) (11)
- Cells, vaccines and the pursuit of precedent. (1968) (11)
- Respiratory virus vaccines. II. Mycoplasma pneumoniae (Eaton agent) vaccines. (1966) (11)
- Studies on lymphogranuloma venereum complement-fixing antigens; fractionation with organic solvents of antigens of the psittacosis-lymphogranuloma venereum group. (1947) (11)
- DURABLE IMMUNITY TWO YEARS AFTER ADMINISTRATION OF ENDERS'S LIVE MEASLES-VIRUS VACCINE WITH IMMUNE GLOBULIN. (1964) (11)
- A FORWARD LOOK AT VIRAL VACCINES: WITH SPECIAL REFERENCE TO A NEW IMMUNOLOGIC ADJUVANT. (1964) (11)
- Respiratory virus vaccines. I. Respiratory syncytial and parainfluenza virus vaccines. (1966) (11)
- Double-Stranded RNA’s in Relation to Interferon Induction and Adjuvant Activity (1971) (11)
- A Field Trial of Combined Measles- Mumps-Rubella Vaccine (1973) (11)
- Characterization of CR326 human hepatitis A virus, a probable enterovirus. (1975) (11)
- Attempts to Interrupt Virus Tumorigenesis by Immunization Using Homologous “Bjorklund-Type” Antigen.∗ (1963) (11)
- Preparation and testing of duck embryo cell culture rubella vaccine. (1969) (11)
- Infectivity stability of live measles-virus vaccine. (1962) (10)
- Serologic responses to split and whole swine influenza virus vaccines in light of the next influenza pandemic. (1977) (10)
- Immune adherence and complement-fixation tests for human hepatitis A. Diagnostic and epidemiologic investigations. (1975) (10)
- Prevention of Viral and Transplant Tumors in Hamsters Employing Killed and Fragmented Homologous Tumor Cell Vaccines∗ (1968) (10)
- Pathogenicity and oncolytic capacity of RI virus strain RI-67 in man. (1956) (10)
- NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. 3. EFFICACY AND TOXICITY STUDIES IN MAN. (1964) (10)
- Adenovirus vaccine; development, field evaluation, and appraisal of the need for vaccination in military and civilian populations. (1958) (9)
- Comparison of the antigenic patterns of influenza A virus strains determined by in ovo neutralization and hemagglutination-inhibition. (1952) (9)
- Persistence of immunity four years following Jeryl Lynn strain live mumps virus vaccine. (1970) (9)
- The roles of early alert and of adjuvant in the control of Hong Kong influenza by vaccines. (1969) (9)
- Immunogenic response to killed measles-virus vaccine. Studies in animals and evaluation of vaccine efficacy in an epidemic. (1962) (9)
- Optimization techniques: Studies in cell culture (1983) (8)
- Infectious hepatitis (hepatitis A) research in nonhuman primates. (1977) (8)
- Antigenicity of Double-Stranded Ribonucleic Acids Including Poly I:C (1972) (8)
- Personal reflections on twentieth century vaccinology. (2003) (8)
- The Development of Live Attenuated Mumps Virus Vaccine in Historic Perspective and Its Role in the Evolution of Combined Measles–Mumps–Rubella (2011) (8)
- New metabolizable immunologic adjuvant for human use. 5. Evaluation of highly purified influenza-virus vaccine in adjuvant 65. (1967) (8)
- Complement-Fixation Reaction of Human Neoplastic Tissue with Sera From Hamsters Bearing Virus-Induced Tumors.∗ (1967) (8)
- Whither immunization against viral infections? (1984) (7)
- Cellular Control of Interferon Production and Release After Treatment with Poly I:C Inducer (1972) (7)
- Acute respiratory illness in volunteers following intramuscular administration of live adenovirus. (1957) (7)
- Influenza B in the Spring of 1965 (1966) (7)
- Improving the heat stability of vaccines: problems, needs, and approaches. (1989) (7)
- Acute respiratory illness caused by adenoviruses; a military problem. (1956) (7)
- CLINICAL-EPIDEMIOLOGIC FINDINGS IN CORYZAVIRUS INFECTIONS. (1963) (7)
- A PROTECTIVE ANTISERUM AGAINST MOUSE PNEUMONITIS VIRUS. (1943) (7)
- Hepatitis B and AIDS and the promise for their control by vaccines. (1988) (7)
- In vivo and in vitro studies of serological specificity among viruses of the psittacosis-lymphogranuloma venereum group. (1952) (6)
- POLIOVIRUS VACCINES IN MINERAL OIL ADJUVANT. II. CLINICAL REACTION AND ANTIBODY RESPONSE. (1963) (6)
- Human cancer virus vaccines and the pursuit of the practical (1974) (6)
- Studies on Induction of Virus from Adenovirus and SV40 Hamster Tumors 2. “Helper” Viruses.∗ (1966) (6)
- Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. II. Development and appraisal of potency of SF-4 (shipping fever) virus vaccine. (1961) (6)
- Measles, mumps and rubella virus vaccines prepared from virus produced by unit process. (1975) (6)
- Virus vaccines (1985) (6)
- Do family planning facilities meet the needs of the sexually active teenagers (1988) (6)
- A FORWARD LOOK AT VIRAL VACCINES: WITH SPECIAL REFERENCE TO A NEW IMMUNOLOGIC ADJUVANT. (1964) (6)
- A guinea pig potency test for adenovirus vaccine. (1960) (6)
- Antibody Response in Man to Hong Kong Influenza Following 1967 Formula Influenza Vaccine in Adjuvant 65 (1969) (6)
- Historical and contemporary perspectives in vaccine developments: from the vantage of cancer. (1992) (6)
- Studies on lymphogranuloma venereum complement-fixing antigens; fractionation with organic solvents of antigens of the psittacosis lymphogranuloma venereum group. (1947) (6)
- Progress toward a live attenuated human hepatitis A virus vaccine. (1983) (6)
- THE ECHO 28-RHINOVIRUS-CORYZAVIRUS (ERC) GROUP OF VIRUSES. (1963) (6)
- POLIOVIRUS VACCINES IN MINERAL OIL ADJUVANT. I. ANIMAL TOXICITY AND SEROLOGIC RESPONSE DATA. (1963) (5)
- Search for Virus in Human Malignancies. 4. Tests of Human Neoplastic Tissues in Sex-Segregated Mice.∗ (1966) (5)
- Immunologic responses in hamsters to homologous tumor antigens measured in vivo and in vitro (1967) (5)
- Effect of Westphal Lipid A on Viral Activities in Mice and Hamsters (1962) (5)
- The Promise and the Reality of Viral Vaccines against Cancer (1993) (5)
- Coloscopy: endoscopic examination of the colon. (1956) (5)
- New Metabolizable Immunologic Adjuvant for Human Use. 4. Development of Highly Purified Influenza Virus Vaccine in Adjuvant 65 (1966) (5)
- Present knowledge of the rhinovirus group of viruses. (1967) (5)
- The control of viral diseases, with special reference to mumps, rubella, and interferon (1968) (5)
- Present knowledge of the rhinovirus group of viruses. (1967) (5)
- Group-specificity of psittacosis-lymphogranuloma venereum group skin test antigens in lymphogranuloma venereum patients. (1958) (5)
- Rhinovirus Infection in Nursery and Kindergarten Children. New Rhinovirus Serotype 54 (1967) (5)
- New metabolizable immunologic adjuvant for human use. IX. Large-scale trials with multiple lots in different regimens. (1969) (5)
- Respiratory viruses and respiratory virus vaccines. (1963) (5)
- Tests in rufiventer and other marmosets of susceptibility to human hepatitis A virus. (1978) (5)
- Tests for Oncogenicity of Viruses Under Conditions of Altered Host and Virus 1 (1971) (5)
- PROSPECTS FOR THE ROLE OF VIRUSES IN HUMAN MALIGNANCY. (1964) (5)
- Search for Virus in Human Malignancies. 2. In vivo Studies.∗ (1962) (5)
- Vaccinology in practical perspective. (1986) (4)
- Development of anal ducts and glands with reference to the pathogenesis of anorectal disease. (1949) (4)
- Stabilized measles vaccine in a novel single-dose delivery system: a practical reality for worldwide elimination of measles. (1983) (4)
- New developments with new vaccines. (1980) (4)
- Laryngocele: an unusual tumor of the neck; case report. (1954) (4)
- Laboratory and Field Investigations of Bovine Myxovirus Parainfluenza 3 Virus and Vaccine (1961) (4)
- Respiratory virus vaccines. 3. Pentavalent respiratory syncytial-parainfluenza-mycoplasma pneumoniae vaccine. (1966) (4)
- International biological standardization in historic and contemporary perspective. (1999) (4)
- Variations in immunogenicity of disrupted cells prepared from an adenovirus-7 hamster tumor cell line. (1971) (4)
- The Frustrating Journey toward an AIDS Vaccine (2000) (4)
- Status report on adenoviruses and Asian influenza. (1958) (4)
- PROSPECTS FOR THE ROLE OF VIRUSES IN HUMAN MALIGNANCY. (1964) (4)
- Combined Measles, Mumps, and Rubella Vaccines (1999) (4)
- Vaccines for the decade of the 1980s and beyond. (1982) (4)
- CHAPTER 19 – Prospects for Vaccines against Cancer (1974) (4)
- Clinical Laboratory Evaluation of Rubella Virus Vaccine Given to Postpartum Women Without Pregnancy Preventive (1973) (3)
- Overview: Past and future of immunologic intervention in the pathogenesis, prophylaxis and therapeusis of hepatitis B (2002) (3)
- A novel single-dose delivery system for vaccines. (1982) (3)
- Microelectrode probes for biomedical applications. (1990) (3)
- Clinical laboratory experiences with a more attenuated Enders' measles virus vaccine (Moraten) combined with smallpox vaccine. (1969) (3)
- Demonstration of Double-Stranded Ribonucleic Acid in Concentrates of RNA Viruses (1972) (3)
- Porcine stress deaths (1992) (3)
- Overview of Vaccinology in Historic and Future Perspective (2003) (3)
- Recombinant yeast hepatitis B vaccine. (1986) (3)
- Overview of viruses, cancer, and vaccines in concept and in reality. (1998) (3)
- Vaccine, chemotherapy, and host resistance approaches to control of viral respiratory disease. (1966) (3)
- Preparation of dried antigen and antiserum for the agglutination-inhibition test for virus influenza. (1951) (3)
- A safe high-speed blendor for processing infectious materials. (1958) (3)
- Lack of identity of polyoma virus and pneumonia virus of mice (PVM). (1960) (3)
- On Use of Urea- and Phenol-Treated Skin Test Antigens for Diagnosis of Lymphogranuloma venereum. (1947) (3)
- Preparation of dried antigen and antiserum for the agglutination-inhibition test for virus influenza. (1951) (3)
- Alopecia in calves associated with milk substitute feeding (1983) (3)
- Historical and contemporary perspectives in vaccine developments: from the vantage of cancer. (1992) (3)
- Cells, vaccines, and the pursuit of precedent. (1968) (3)
- Respiratory virus vaccines. VI. Serologic responses to heptavalent vaccine among young children in families. (1967) (3)
- Occurrence and significance of adenovirus antibody in sera of recruit and cadre military personnel. (1958) (3)
- Field evaluation of combined more attenuated live measles (Moraten)-smallpox vaccine in Honduras and Costa Rica. (1971) (2)
- Jeryl Lynn strain live mumps virus vaccine. (1969) (2)
- Perspectives for testing safety of live measles vaccine. (1962) (2)
- Cells, vaccines and the pursuit of precedent. (1968) (2)
- Perspectives in the control of viral diseases including cancer. (1972) (2)
- The Quality of Measles Virus Vaccine (1965) (2)
- A safe high-speed blendor for processing infectious materials. (1958) (2)
- Immunologic response in hamsters to homologous tumor antigens measured in vivo and in vitro. (1967) (2)
- Hepatitis viruses and vaccines (1978) (2)
- High-resolution flow-zonal centrifuge system. (1979) (2)
- ECHO virus, type 25, in respiratory illness. Case report. (1963) (2)
- Strategies for the achievement of prophylactic vaccination against HIV. (1996) (2)
- New developments with new vaccines. (1980) (2)
- Human cancer virus vaccines (1974) (2)
- Respiratory virus vaccines. IV. Heptavalent respiratory syncytial-parainfluenza-mycoplasma-influenza vaccine in institutionalized persons. (1966) (2)
- Search for Virus in Human Malignancies. 3. Sex Segregation and Neoplasia in ICR/Ha Mice.∗ (1963) (2)
- The role of industry in the development of new biologicals. (1977) (2)
- Three Decades of Hepatitis Vaccinology in Historic Perspective. A Paradigm of Successful Pursuits (2011) (2)
- A pattern of antigen variation. (1952) (2)
- Present status of recombinant hepatitis B vaccine. (1988) (2)
- Conclusions: in pursuit of an AIDS virus vaccine. (1989) (2)
- An evaluation of the surgical treatment of carcinoma of the stomach. (1956) (2)
- Concerns for the use of continuous cell lines and certain promoters for producing vaccine antigens by recombinant technology. (1987) (1)
- Cryosurgical Treatment of Primary SV40 Viral and Adenovirus 7 Transplant Tumors in Hamsters∗ (1968) (1)
- Safety Assessment of Poly I: C in NZB/NZW Mice (1975) (1)
- How does a viral infection trigger an autoimmune disease (1995) (1)
- Comparative Studies of SV40 and Adenovirus Oncogenesis in Random Bred and Inbred Hamsters 1 (1971) (1)
- Vaccines, human experimentation, and ethics in evolutionary perspective. (1998) (1)
- Viral Hepatitis and Liver Disease: Editor, A.J. Zuckerman, Alan R. Liss, Inc., New York, 1988, 1160 pp., $350.00, ISBN 0-8451-4247-X (1989) (1)
- Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells (1980) (1)
- Preparation of Measles Antiserum in Horses (1962) (1)
- Vaccines for the decade of the 1980s and beyond. (1982) (1)
- Automated cytopathic effect (CPE) assays. (1983) (1)
- Problems and potentials for human viral cancer vaccines. (1972) (1)
- The 1975 I.R.I. Achievement Award Lecture: Managing Research in the Health Sciences (1976) (1)
- Perspectives in Disease Prevention by Vaccines (1987) (1)
- Status report on adenoviruses and Asian influenza. (1958) (1)
- Vaccination against mumps. (1968) (1)
- What is the most important achievement in viral immunology in the last five years (1995) (1)
- The Evaluation of Vaccines (1985) (1)
- PURSUIT OF PRACTICABLE IMMUNOGENS FOR HUMAN NEOPLASIA (1968) (1)
- Pneumonia and meningoencephalitis in a female adolescent. Case report. (1984) (1)
- Use of poly I-poly C in the prophylaxis and treatment of acute viral infections. (1969) (1)
- New Metabolizable Immunologic Adjuvant∗ for Human Use 8. Chronic Toxicity and Teratogenic Tests (1968) (1)
- Detection of poliovirus I in monkey kidney cultures inoculated with overwhelming dose of adenovirus 4. (1958) (1)
- IXth International Congress of Infectious and Parasitic Diseases Munich, July 20–26, 1986 (2005) (0)
- A simple tissue washer. (1951) (0)
- Failure of Shier's Chemical Vaccine to Protect BALB/c Mice Against Transplant and Chemically Induced Tumors 1 (1974) (0)
- New immunologic adjuvant for human use. II. Short-term animal toxicity tests (1964) (0)
- Studies of immunization with three types of combined viral vaccines (1971) (0)
- [Advances and new approach in the control of virus diseases in man]. (1970) (0)
- Part II. Mechanism of DNA Uptake and Antigen Presentation: Fate and Function of Foreign Nucleic Acids Use of Plasmid DNA for Direct Gene Transfer and Immunization. (1995) (0)
- The Newer Live Virus Vaccines (2009) (0)
- Is immunization with naked DNA the most important factor in the development of vaccines (1995) (0)
- Long-Term Follow-up for Immunity After Monovalent or Combined Live Measles, Mumps, and Rubella Virus Vaccines (1975) (0)
- Subject Index Vol. 45, 2002 (2003) (0)
- Preparation and Research on Meningococcal Vaccines (1972) (0)
- DISCUSSION (1971) (0)
- [Research of infectious hepatitis (hepatitis A) in non-human primates]. (1976) (0)
- A pattern of antigen variation. (1952) (0)
- Respiratory Tract Diseases (1961) (0)
- Immunologic Attack on Neoplasia (1966) (0)
- Discussion. Mycoplasma from human respiratory and urogenital tract. (1967) (0)
- A tribute to Dr. Friedrich W. Deinhardt M.D. 1926-1992. (1993) (0)
- A review of DNA vaccines (2007) (0)
- Discussion. Mycoplasma from human respiratory and urogenital tract. (1967) (0)
- The polysaccharide / protein conjugate, process for its preparation and its use in a vaccine (1984) (0)
- Vaccinology in practical perspective. (1986) (0)
- Present status of recombinant hepatitis B vaccine. (1988) (0)
- Letter from Maurice R. Hilleman to Paul Berg (1973) (0)
- Viral vaccines in historical perspective. (1995) (0)
- Toward prophylaxis of prenatal infection by viruses. (1969) (0)
- The control of viral respiratory illnesses of man. (1962) (0)
- Two-team abdomino-perineal operation for carcinoma of rectum and rectosigmoid. (1947) (0)
- An automatic pipette for preparing serial dilutions. (1952) (0)
- A tribute to Professor Friedrich W. Deinhardt, scientist and statesman, 1926–1992 (1993) (0)
- Visualization of bacterial polysaccharides by scanning transmission electron microscopy. (1983) (0)
- A simple tissue washer. (1951) (0)
- The enhancement and properties of the complement-fixing antigens of lymphogranuloma venereum. (1946) (0)
- Invited Discussions Double-Stranded Polynucleotides as Interferon Inducers (0)
- Use of poly I-poly C in the prophylaxis and treatment of acute viral infections. (1969) (0)
- Regularly scheduled versus as-needed use of inhaled beta agonists in the treatment of asthma. (1992) (0)
- Vaccine, chemotherapy, and host resistance approaches to control of viral respiratory disease. (1966) (0)
- Prophylaxe intrauteriner Virusinfektion (1970) (0)
- Toward Prophylaxis of Prenatal Infection by Viruses (1969) (0)
- ON THE ONCOGENICITY OF ORDINARY VIRUSES. (1965) (0)
- The control of viral respiratory illnesses of man. (1962) (0)
- What are the major goals of research in viral immunology (1995) (0)
- Mumps vaccination. (1970) (0)
- Fritz will be remembered, for he was a servant to mankind and the world is a better place, because he was here. On this last fallen leaf, we inscribe our final tribute to Fritz, 'Farewell, good Friend; well done!' (1992) (0)
- Preface (1995) (0)
- Lactose absorption, milkconsumption, andfasting blood glucose concentrations inwomenwithidiopathic osteoporosis (1986) (0)
- Mechanical apparatus for washing tissue cultures in tubes. (1955) (0)
- Conclusions: in pursuit of an AIDS virus vaccine. (1989) (0)
- The role of industry in the development of new biologicals. (1977) (0)
- A process for increasing the activity of a vaccine. (1969) (0)
- Human papillomavirus vaccination workshop, Helsinki 10.01.2000: Structured discussion (2000) (0)
- On the oncogenicity of ordinary viruses (2005) (0)
- Vaccination against mumps. (1968) (0)
- Hepatitis B can teach about how to approach the development of a vaccine against AIDS (1996) (0)
- Prof. Dr. F. Deinhardt — 60 years (1986) (0)
- DISCUSSION (1967) (0)
- A device for storage and dispensing of vaccines and method of loading of the device (1976) (0)
- Contents Vol. 45, 2002 (2003) (0)
- New Hepatitis A and B Vaccines: Summary of a Specialty Session (1994) (0)
This paper list is powered by the following services:
Other Resources About Maurice Hilleman
What Schools Are Affiliated With Maurice Hilleman?
Maurice Hilleman is affiliated with the following schools:
